The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KRYS · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | KRYS | CODA | MMM | TMO |
|---|---|---|---|---|
| Moat Score (0–100) | 62 (highest) | 62 (highest) | 62 (highest) | 62 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 100 (highest) | 40 | 52 | 92 |
| Pricing power | — | 98 (highest) | 72 | 94 |
| Returns on capital | 4 | 63 | 97 (highest) | 23 |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 45 | 25 |
| Capital discipline | 44 | 9 | 45 | 75 (highest) |
| Price vs. high estimate | 8052% above high estimate | 52% above high estimate (largest discount to high estimate) | 75% above high estimate | 69% above high estimate |
| Market cap | $9.9B | $112.7M | $84.5B | $195.5B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |